Quick Answer
Atea Pharmaceuticals, Inc. reported Total Revenue of $351.37 million for the year ending 2021.
- Atea Pharmaceuticals, Inc. showed an increase of +622.5% in Total Revenue from 2020 to 2021.
- This data is from Atea Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2023.
- XBRL data for this metric is available from 2020 to 2021 (2 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $65.99 million | Q2 2021: $60.39 million | Q3 2021: $32.81 million.
- Historical annual values: Fiscal year 2021: $351.37 million | Fiscal year 2020: $48.63 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: